Both fluorouracil (5-FU) and irinotecan (CPT-11 [Camptosar]) have shown activity in metastatic colorectal cancer and are approved for its treatment in the United States. Preclinical experiments in cell cultures and human tumor
Charles Erlichman, MD
Advertisement
Articles by Charles Erlichman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC
3
Navigating New Horizons in Neuroendocrine Prostate Cancer
4
Neoadjuvant Strategies and Early Biomarker Testing in EGFR-Mutated NSCLC
5